Keywords
Diagnosis
Latin america
Colombia
Asthma
Allergists
Intradermal tests
Patch tests
Nasal provocation tests
Urticaria
Tolerance induction
Allergens
Immunotherapy
Ecuador
Mexico
Peru
Disease
How to Cite
Abstract
Background: Allergic diseases affect approximately 25% of the global population. Accurate diagnosis is essential to prevent unnecessary restrictions and to implement precision medicine tailored to each patient’s specific needs.
Objective: This manual establishes clear guidelines for the main clinical allergy procedures, detailing their indications, diagnostic performance, and applicability in the Latin American context.
Methods: The Colombian Association of Allergy, Asthma, and Immunology (ACAAI) conducted a thorough literature review to compile the most utilized clinical allergy procedures. We provide specific recommendations for each procedure, incorporating operational guidelines, diagnostic accuracy, and clinical indications. Furthermore, allergists from various Latin American countries reviewed this manual to ensure its regional applicability.
Results: We formulated evidence-based and operationally feasible recommendations for the execution and interpretation of nine critical allergy procedures: 1) skin prick tests, 2) intradermal tests, 3) patch tests, 4) nasal provocation tests, 5) oral provocation tests, 6) provocation tests for inducible urticarias, 7) drug desensitization, 8) food tolerance induction, and 9) allergen immunotherapy. Our document was validated by allergists from Ecuador, Mexico, and Peru, confirming its relevance and applicability in their clinical practices.
Conclusion: This position paper delivers a practical manual for executing and interpreting allergy procedures. Its implementation will enhance diagnostic and therapeutic precision, ensuring a safe and effective approach to allergic disease management across Latin America.
Keywords: Allergy; Diagnosis; Latin america; Colombia; Asthma; Allergists; Intradermal tests; Patch tests; Nasal provocation tests; Urticaria; Tolerance induction; Allergens; Immunotherapy; Ecuador; Mexico; Peru; Disease.
References
1. Bognanni A, Fiocchi A, Arasi S, Chu DK, Ansotegui I, Assa'ad AH, et al. World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) guideline update - XII - Recommendations on milk formula supplements with and without probiotics for infants and toddlers with CMA. World Allergy Organ J. 2024;17(4):100888.
2. Sánchez J, Sánchez A, Cardona R. [Common questions about allergy. Practical approach to diagnosis and management in primary care]. Rev Alerg Mex. 2018;65(3):117-27.
3. Sánchez J, Alvarez L, García E. Real-world study: drug reduction in children with allergic rhinitis and asthma receiving immunotherapy. Immunotherapy. 2023;15(4):253-66.
4. Kubota K, Nagakura KI, Ejiri Y, Sato S, Ebisawa M, Yanagida N. Natural history of cow's milk allergy in children aged 6-12 years. Pediatr Allergy Immunol. 2023;34(12):e14064.
5. Ansotegui IJ, Melioli G, Canonica GW, Caraballo L, Villa E, Ebisawa M, et al. IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper. World Allergy Organ J. 2020;13(2):100080.
6. Carmona-Gil AM, Sánchez J, Maldonado-Estrada J. Evaluation of Skin Prick-Test Reactions for Allergic Sensitization in Dogs With Clinical Symptoms Compatible With Atopic Dermatitis. A Pilot Study. Front Vet Sci. 2019;6:448.
7. Bousquet J, Heinzerling L, Bachert C, Papadopoulos NG, Bousquet PJ, Burney PG, et al. Practical guide to skin prick tests in allergy to aeroallergens. Allergy. 2012;67(1):18-24.
8. Sekerel BE, Sahiner UM, Bousquet J, Demoly P, Zuberbier T, Carlsen KH, et al. Practical guide to skin prick tests in allergy to aeroallergens: some concerns. Allergy. 2012;67(3):442; author reply 3.
9. Xie Q, Xue W. IgE-Mediated food allergy: Current diagnostic modalities and novel biomarkers with robust potential. Crit Rev Food Sci Nutr. 2023;63(29):10148-72.
10. Burbach G, Heinzerling L, Edenharter G, Bachert C, Bindslev-Jensen C, Bonini S, et al. GA(2)LEN skin test study II: clinical relevance of inhalant allergen sensitizations in Europe. Allergy. 2009;64(10):1507-15.
11. Heinzerling LM, Burbach GJ, Edenharter G, Bachert C, Bindslev-Jensen C, Bonini S, et al. GA(2)LEN skin test study I: GA(2)LEN harmonization of skin prick testing: novel sensitization patterns for inhalant allergens in Europe. Allergy. 2009;64(10):1498-506.
12. Heinzerling L, Mari A, Bergmann KC, Bresciani M, Burbach G, Darsow U, et al. The skin prick test - European standards. Clin Transl Allergy. 2013;3(1):3.
13. Santos AF, Riggioni C, Agache I, Akdis CA, Akdis M, Alvarez-Perea A, et al. EAACI guidelines on the diagnosis of IgE-mediated food allergy. Allergy. 2023;78(12):3057-76.
14. Dreborg S. Diagnosis of food allergy: tests in vivo and in vitro. Pediatr Allergy Immunol. 2001;12 Suppl 14:24-30.
15. Sánchez A, Cardona R, Munera M, Calvo V, Tejada-Giraldo M, Sánchez J. Nasal Provocation Test with Cat and Dog Extracts: Results according to Molecular Components. Pulm Med. 2020;2020:6365314.
16. Santamaría L, Calle A, Tejada-Giraldo Biol M, Calvo V, Sánchez J, Cardona R. Nasal specific IgE to Der p is not an acceptable screening test to predict the outcome of the nasal challenge test in patients with non-allergic rhinitis. World Allergy Organ J. 2020;13(9):100461.
17. Sampson HA, Arasi S, Bahnson HT, Ballmer-Weber B, Beyer K, Bindslev-Jensen C, et al. AAAAI-EAACI PRACTALL: Standardizing oral food challenges-2024 Update. Pediatr Allergy Immunol. 2024;35(11):e14276.
18. Akten HS, Tunakan Dalgc C, Demir M, Okan K, Yildirim O, Gumusburun R, et al. Early testing and grade of the reaction are affecting factors of skin test positivity in β-Lactam allergies. Allergy Asthma Proc. 2024;45(4):e23-e30.
19. Schmid AA, Hungerbühler MN, Lombardo P, Boehm IB. Intradermal testing of iodinated contrast media: Should we test up to pure or with diluted compounds only? Fundam Clin Pharmacol. 2024;38(4):789-98.
20. Caliskan N, Yildirim G, Bologur H, Gungor H, Karaca Sahin M, Erbay F, et al. Local anesthetics allergy in children: Evaluation of diagnostic tests with Real-Life data. Pediatr Allergy Immunol. 2024;35(2):e14097.
21. Lee SJ, Lee IH, Kim S, Lee JM, Chae YS, Park HK. Effectiveness of Carboplatin-Prescreening Intradermal Skin Tests to Reduce Unanticipated Immediate Hypersensitivity Reactions: A Comparative Study. J Allergy Clin Immunol Pract. 2024;12(4):998-1005.e3.
22. Barbaud A, Garvey LH, Torres M, Laguna JJ, Arcolaci A, Bonadonna P, et al. EAACI/ENDA position paper on drug provocation testing. Allergy. 2024;79(3):565-79.
23. Brockow K, Garvey LH, Aberer W, Atanaskovic-Markovic M, Barbaud A, Bilo MB, et al. Skin test concentrations for systemically administered drugs -- an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy. 2013;68(6):702-12.
24. Torres MJ, Romano A, Mayorga C, Moya MC, Guzman AE, Reche M, et al. Diagnostic evaluation of a large group of patients with immediate allergy to penicillins: the role of skin testing. Allergy. 2001;56(9):850-6.
25. Balakirski G, Merk HF. Cutaneous allergic drug reactions: update on pathophysiology, diagnostic procedures and differential diagnosic. Cutan Ocul Toxicol. 2017;36(4):307-16.
26. Romano A, Blanca M, Torres M, Bircher A, Aberer W, Brockow K, et al. Diagnosis of nonimmediate reactions to beta-lactam antibiotics. Allergy. 2004;59(11):1153-60.
27. Konstantinou G, Asero R, Maurer M, Sabroe R, Schmid-Grendelmeier P, Grattan C. EAACI/GA(2)LEN task force consensus report: the autologous serum skin test in urticaria. Allergy. 2009;64(9):1256-68.
28. DeKoven JG, Warshaw EM, Reeder MJ, Atwater AR, Silverberg JI, Belsito DV, et al. North American Contact Dermatitis Group Patch Test Results: 2019-2020. Dermatitis. 2023;34(2):90-104.
29. Rodriguez-Homs LG, Taylor J, Liu B, Green CL, Brod B, Jacob SE, et al. Patch Test Practice Patterns of Members of the American Contact Dermatitis Society. Dermatitis. 2020;31(4):272-5.
30. DeKoven JG, Warshaw EM, Belsito DV, Sasseville D, Maibach HI, Taylor JS, et al. North American Contact Dermatitis Group Patch Test Results 2013-2014. Dermatitis. 2017;28(1):33-46.
31. Thaiwat S, Rojanapanthu P. Cutaneous adverse drug eruption: the role of drug patch testing. Int J Dermatol. 2023;62(1):108-14.
32. Sánchez J, Álvarez L, Die S, Miquel-Miquel J, Velásquez M. Diagnostic accuracy of patch testing based in clinical response to contact allergen restrictions in allergic contact dermatitis. Eur Ann Allergy Clin Immunol. 2024.
33. Cho SH, Nanda A, Keswani A, Adinoff A, Baroody FM, Bernstein JA, et al. "Nasal Allergen Challenge (NAC): Practical Aspects and Applications from an EU/US perspective: A Workgroup Report of the AAAAI Rhinitis, Rhinosinusitis and Ocular Allergy Committee". J Allergy Clin Immunol. 2023.
34. Augé J, Vent J, Agache I, Airaksinen L, Campo Mozo P, Chaker A, et al. EAACI Position paper on the standardization of nasal allergen challenges. Allergy. 2018;73(8):1597-608.
35. Krzych-Fałta E, Furmańczyk K, Samoliński B. Specificity and sensitivity assessment of selected nasal provocation testing techniques. Postepy Dermatol Alergol. 2016;33(6):464-8.
36. García E, Ardila JC, Crespo N, Chapman E, Ocampo J, Olivares M, et al. Selection of allergen extract for immunotherapy in polysensitized allergic rhinitis patients. Immunotherapy. 2024;16(9):623-34.
37. Toca MC, Morais MB, Vázquez-Frias R, Becker-Cuevas DJ, Boggio-Marzet CG, Delgado-Carbajal L, et al. Consensus on the diagnosis and treatment of cow's milk protein allergy of the Latin American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Rev Gastroenterol Mex (Engl Ed). 2022;87(2):235-50.
38. Moral L, Toral T, Muñoz C, Marco N, García-Avilés B, Murcia L, et al. Direct oral challenge for immediate and non-immediate beta-lactam allergy in children: A real-world multicenter study. Pediatr Allergy Immunol. 2024;35(3):e14096.
39. Broyles AD, Banerji A, Barmettler S, Biggs CM, Blumenthal K, Brennan PJ, et al. Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs. J Allergy Clin Immunol Pract. 2020;8(9S):S16-S116.
40. Santos AF, Riggioni C, Agache I, Akdis CA, Akdis M, Alvarez-Perea A, et al. EAACI guidelines on the management of IgE-mediated food allergy. Allergy. 2025;80(1):14-36.
41. Sampson HA, Gerth van Wijk R, Bindslev-Jensen C, Sicherer S, Teuber SS, Burks AW, et al. Standardizing double-blind, placebo-controlled oral food challenges: American Academy of Allergy, Asthma & Immunology-European Academy of Allergy and Clinical Immunology PRACTALL consensus report. J Allergy Clin Immunol. 2012;130(6):1260-74.
42. Nowak-Wegrzyn A, Assa'ad AH, Bahna SL, Bock SA, Sicherer SH, Teuber SS, et al. Work Group report: oral food challenge testing. J Allergy Clin Immunol. 2009;123(6 Suppl):S365-83.
43. Magerl M, Altrichter S, Borzova E, Giménez-Arnau A, Grattan CE, Lawlor F, et al. The definition, diagnostic testing, and management of chronic inducible urticarias - The EAACI/GA(2) LEN/EDF/UNEV consensus recommendations 2016 update and revision. Allergy. 2016;71(6):780-802.
44. Sánchez J, Amaya E, Acevedo A, Celis A, Caraballo D, Cardona R. Prevalence of Inducible Urticaria in Patients with Chronic Spontaneous Urticaria: Associated Risk Factors. J Allergy Clin Immunol Pract. 2017;5(2):464-70.
45. Komarow HD, Arceo S, Young M, Nelson C, Metcalfe DD. Dissociation between history and challenge in patients with physical urticaria. J Allergy Clin Immunol Pract. 2014;2(6):786-90.
46. Hong DIC. Desensitization for Allergic Reactions to Chemotherapy. Yonsei Med J. 2019;60(2):119-25.
47. Sabouraud M, Biermé P, Andre-Gomez SA, Villard-Truc F, Corréard AK, Garnier L, et al. Oral immunotherapy in food allergies: A practical update for pediatricians. Arch Pediatr. 2021;28(4):319-24.
48. Jeimy S, Yu N, Chan ES, Cook V. Oral immunotherapy for treatment of food allergy in infants and preschoolers. CMAJ. 2024;196(23):E790-E1.
49. Peters RL, Krawiec M, Koplin JJ, Santos AF. Update on food allergy. Pediatr Allergy Immunol. 2021;32(4):647-57.
50. Rodríguez Del Río P, Álvaro-Lozano M, Arasi S, Bazire R, Escudero C, Patel N, et al. Evaluation of clinical outcomes of efficacy in food allergen immunotherapy trials, COFAITH EAACI task force. Allergy. 2024;79(4):793-822.
51. Yepes-Nuñez JJ, Guyatt GH, Gómez-Escobar LG, Pérez-Herrera LC, Chu AWL, Ceccaci R, et al. Allergen immunotherapy for atopic dermatitis: Systematic review and meta-analysis of benefits and harms. J Allergy Clin Immunol. 2023;151(1):147-58.
52. Wollenberg A, Kinberger M, Arents B, Aszodi N, Avila Valle G, Barbarot S, et al. European guideline (EuroGuiDerm) on atopic eczema: part I - systemic therapy. J Eur Acad Dermatol Venereol. 2022;36(9):1409-31.
53. Tkacz JP, Rance K, Waddell D, Aagren M, Hammerby E. Real-world evidence costs of allergic rhinitis and allergy immunotherapy in the commercially insured United States population. Curr Med Res Opin. 2021;37(6):957-65.
54. Parra-Padilla D, Zakzuk J, Carrasquilla M, Alvis-Guzmán N, Dennis R, Rojas MX, et al. Cost-effectiveness of the subcutaneous house dust mite allergen immunotherapy plus pharmacotherapy for allergic asthma: A mathematical model. Allergy. 2021;76(7):2229-33.
55. Ruëff F, Bauer A, Becker S, Brehler R, Brockow K, Chaker AM, et al. Diagnosis and treatment of Hymenoptera venom allergy: S2k Guideline of the German Society of Allergology and Clinical Immunology (DGAKI) in collaboration with the Arbeitsgemeinschaft für Berufs- und Umweltdermatologie e.V. (ABD), the Medical Association of German Allergologists (AeDA), the German Society of Dermatology (DDG), the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNOKC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Allergy and Environmental Medicine (GPA), German Respiratory Society (DGP), and the Austrian Society for Allergy and Immunology (ÖGAI). Allergol Select. 2023;7:154-90.
56. Dhami S, Zaman H, Varga EM, Sturm GJ, Muraro A, Akdis CA, et al. Allergen immunotherapy for insect venom allergy: a systematic review and meta-analysis. Allergy. 2017;72(3):342-65.
57. Norelli F, Gueli V, Bonadonna P. Hymenoptera venom allergy in children and adolescents. Curr Opin Allergy Clin Immunol. 2024.
58. Arenas-Soto C, Sanclemente-Mesa G, Yepes-Nuñez J, Chaparro-Reyes D, Sánchez J. Diagnóstico y tratamiento de la dermatitis atópica en Colombia . Actualización de la guía de práctica clínica. Rev Asoc Colomb Dermatol Cir Dermatol. 2024;32(4).
59. Kappen J, Diamant Z, Agache I, Bonini M, Bousquet J, Canonica GW, et al. Standardization of clinical outcomes used in allergen immunotherapy in allergic asthma: An EAACI position paper. Allergy. 2023;78(11):2835-50.
60. Julijana A, Dimitrios M, George K, Etleva Q, Mirela H, Sybi M, et al. Allergen immunotherapy adverse events in adults with respiratory allergies-data from ADER: An EAACI task force report. Allergy. 2024.
61. Sánchez J, Cardona R, Caraballo L, Serrano C, Ramírez R, Díez S, et al. [Allergen immunotherapy: Mechanisms of action, and therapeutic and socioeconomic impact Consensus of the Asociación Colombiana de Alergia, Asma e Imunología]. Biomedica. 2016;36(3):463-74.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2025 Revista Alergia México